158 related articles for article (PubMed ID: 2751268)
81. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance.
Hasselbalch H; Jensen BA
Eur J Haematol; 1990 Mar; 44(3):172-8. PubMed ID: 2328790
[TBL] [Abstract][Full Text] [Related]
82. [Anatomo-pathologic forms of lymphoid and lymphoreticular fibrosis of the bone marrow].
Duhamel G; Stachowiak J
Ann Med Interne (Paris); 1976 Apr; 127(4):287-94. PubMed ID: 1015721
[TBL] [Abstract][Full Text] [Related]
83. Prognostic factors in myelofibrosis.
Manoharan A; Smart RC; Pitney WR
Pathology; 1982 Oct; 14(4):455-61. PubMed ID: 7155637
[TBL] [Abstract][Full Text] [Related]
84. Current perspective in agnogenic myeloid metaplasia.
Tefferi A; Silverstein MN
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():169-71. PubMed ID: 8951788
[TBL] [Abstract][Full Text] [Related]
85. Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance.
Lazzarino M; Morra E; Castello A; Inverardi D; Coci A; Pagnucco G; Magrini U; Zei G; Bernasconi C
Br J Haematol; 1986 Oct; 64(2):227-40. PubMed ID: 3465364
[TBL] [Abstract][Full Text] [Related]
86. Correlation of radiologic, histologic, and clinical findings in agnogenic myeloid metaplasia.
Pettigrew JD; Ward HP
Radiology; 1969 Sep; 93(3):541-8. PubMed ID: 5822732
[No Abstract] [Full Text] [Related]
87. Bone marrow fibre production in myelofibrosis: a quantitative study.
Bentley SA; Herman CJ
Br J Haematol; 1979 May; 42(1):51-9. PubMed ID: 465360
[TBL] [Abstract][Full Text] [Related]
88. Erythropoiesis in primary (idiopathic) osteomyelofibrosis: quantification, PCNA-reactivity, and prognostic impact.
Thiele J; Windecker R; Kvasnicka HM; Titius BR; Zankovich R; Fischer R
Am J Hematol; 1994 May; 46(1):36-42. PubMed ID: 7910431
[TBL] [Abstract][Full Text] [Related]
89. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.
Wolf BC; Neiman RS
Blood; 1985 Apr; 65(4):803-9. PubMed ID: 3978228
[TBL] [Abstract][Full Text] [Related]
90. Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.
Kvasnicka HM; Thiele J; Regn C; Zankovich R; Diehl V; Fischer R
Ann Hematol; 1999 Feb; 78(2):65-72. PubMed ID: 10089020
[TBL] [Abstract][Full Text] [Related]
91. Osteomyelosclerosis with thalassemia trait: report of a rare association, study of platelet function tests and review of literature.
Singh DK; Mahajan D; Nigam S; Singh T
Hematology; 2008 Apr; 13(2):83-7. PubMed ID: 18616873
[TBL] [Abstract][Full Text] [Related]
92. Histo-immunology of myelofibrosis: a study of 100 cases.
Barge J; Slabodsky-Brousse N; Bernard JF
Biomedicine; 1978 Apr; 29(2):73-5. PubMed ID: 352422
[TBL] [Abstract][Full Text] [Related]
93. Agnogenic myeloid metaplasia, portal hypertension, and sinusoidal abnormalities.
Roux D; Merlio JP; Quinton A; Lamouliatte H; Balabaud C; Bioulac-Sage P
Gastroenterology; 1987 Apr; 92(4):1067-72. PubMed ID: 3493936
[TBL] [Abstract][Full Text] [Related]
94. Liver involvement at diagnosis of primary myelofibrosis: a clinicopathological study of twenty-two cases.
Pereira A; Bruguera M; Cervantes F; Rozman C
Eur J Haematol; 1988 Apr; 40(4):355-61. PubMed ID: 3366226
[TBL] [Abstract][Full Text] [Related]
95. Resident bone marrow macrophages in idiopathic (primary) myelofibrosis (IMF): a histochemical and morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Boeltken B
Leuk Res; 1999 Nov; 23(11):983-5. PubMed ID: 10576501
[TBL] [Abstract][Full Text] [Related]
96. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines.
Barosi G
J Clin Oncol; 1999 Sep; 17(9):2954-70. PubMed ID: 10561375
[TBL] [Abstract][Full Text] [Related]
97. Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET).
Barosi G; Bordessoule D; Briere J; Cervantes F; Demory JL; Dupriez B; Gisslinger H; Griesshammer M; Hasselbalch H; Kusec R; Le Bousse-Kerdiles MC; Liberato NL; Marchetti M; Reilly JT; Thiele J;
Blood; 2005 Oct; 106(8):2849-53. PubMed ID: 15994287
[TBL] [Abstract][Full Text] [Related]
98. Spontaneous hematologic remission in agnogenic myeloid metaplasia.
Shreiner DP
Am J Med; 1976 Jun; 60(7):1014-8. PubMed ID: 937347
[TBL] [Abstract][Full Text] [Related]
99. The prognostic impact of bone marrow fibrosis in primary myelofibrosis.
Guglielmelli P; Vannucchi AM;
Am J Hematol; 2016 Oct; 91(10):E454-5. PubMed ID: 27416333
[No Abstract] [Full Text] [Related]
100. The prognostic impact of bone marrow fibrosis in primary myelofibrosis.
Elliott MA; Tefferi A
Am J Hematol; 2016 Oct; 91(10):E454. PubMed ID: 27342701
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
